Genkicell Chain Invited to China to Communicate about Project Landing

TOKYO, Dec. 6, 2018 /PRNewswire/ — Genkicell Chain, Japan’s well-known One Health Blockchain project, accompanied by a Japanese delegation on high-tech innovation, recently had a one-week investigation, exchange and visit to three Chinese cities, Nanjing, Hangzhou and Jinhua, to ascertain the potential in the Chinese market and seek opportunities of cooperation in the fields of blockchain, artificial intelligence, cloud computing, big data and One Health. Genkicell Chain’s team members included the CEO, Shota Awata, and the Chief Medical Officer (CMO), Kintsu Masayuki, among other members. The delegation included famous Japanese investors, well-known consortiums and entrepreneurs, as well as the political and business class, including former Senator of Aichi Prefecture, Misako Yasui; JBA legal counsel and member of Cryptocurrency Legislative Committee at Japanese Financial Services Agency (FSA, the financial regulator of Japan), Masataka Ogasawara; and the chairman of global asset management company, Union Capital Group, Tomita Takashi.

Shota Awata had mentioned earlier in a live broadcast interview with a well-known media in US blockchain that the current friendly diplomacy between Japan and the Chinese government would be beneficial for Genkicell’s plan to launch in China. The project itself is also related to China’s famous blockchain projects – Ontology and Juyaotang® (the producer and supplier of China’s third largest Chinese herbal medicine). In addition, it is related to other local Chinese projects and companies that have established good relationships with Genkicell.

The trip to China mainly focused on topics such as project landing, solutions to the problems caused by the aging society, development of the Internet industry, and big data information. The delegates also communicated these topics to the related governments of Nanjing, Hangzhou and Jinhua cities.

China’s Yangtze River Delta region has been regarded as a strategic emerging industry and the core of development likely to accelerate independent innovation as well as promote economic restructuring. The region also actively responds to the National “Three-Year Action Plan” (Three-Year Action Plan for the Integration of the Yangtze River Delta Region – (2018-2020)). The main goal of this plan is to build a world-class industrial cluster aimed at optimizing the layout of key industries and promote the deep integration of the industrial chain. After the G20 summit, Hangzhou City, as the organizer, proposed the direction of “building the first city of digital economy” and jointly promoted technological innovations, including cloud computing, big data, Internet of Things, artificial intelligence, and cooperatively building the Yangtze River Delta region into a global digital economy. Additionally, they aim to develop the highlands. As such, the blockchain technology in China’s Yangtze River Delta region has been accelerated to attract the attention of many Japanese developers.

Zhongyu Chen, the chairman of the Zhejiang Normal University Committee and professor at the School of Mathematical and Information Engineering and the Institute of Blockchain, strongly supports Genkicell’s idea of landing in China and believes that Genkicell has potential, especially since the aging society in both Japan and China is becoming increasingly severe. The One Health industry is becoming a major industrial form of domestic demand. Therefore, it is necessary to encourage and support its implementation and solve One Health problems using blockchain technology.

Genkicell Chain also initiated their upcoming application – GEN (GID). Shota Awata gave a detailed introduction to the project on behalf of Genkicell and explained the GID function in the GEN series products.

GEN (GID) is a global decentralized health management application that applies Genkicell’s modular infrastructure to easily collect health data from hospitals, laboratories and IoT devices via scalable interfaces. It can also effectively conduct health prediction and prevention by building user biometric data quantification. At the same time, it helps enterprises and service organizations to reduce operating costs, provide data foundations for hospitals and research institutions, and promote the accelerated development of One Health industries.

Since China is the most populated country worldwide, it is possible that a large number of people suffer chronic diseases. In particular, data indicates that nearly 300 million people suffer from chronic diseases and an estimated 8 billion consultations are carried out every year. Meanwhile, the number of medical examinations is about 500 million, with medical examinations accounting for about 95% of China’s health management services. Therefore, the application of GEN (GID), a global decentralized health management App, can effectively solve problems such as huge operational costs, health prediction, and prevention.

Jian Wang, deputy director of Zhejiang Provincial Department of Commerce, also expressed that he expects the Genkicell project to be beneficial and that the project will be landed after the inspection.

More information about Genkicell Chain:
Telegram EN:

Cision View original content:

Related Post